Trials of aliskiren for CAD and otamixaban for NSTE-ACS, chronic care management for substance dependence, and more.
- Author
- American Medical Association
- Published
- Tue 17 Sep 2013
- Episode Link
- http://dx.doi.org/10.1001/jama.2013.5312
Editor's Audio Summary by Phil B. Fontanarosa, MD, MBA, Executive Editor, the Journal of the American Medical Association, for the September 18, 2013 issue
